Despite a large portion of the Rs 91 crore budget remaining unspent, the State Health Coordinator has requested additional ...

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft demand for gene therapies among haemophilia patients and physicians.

Maharashtra haemophilia patients face medicine shortages, forcing travel to Gujarat for treatment, risking health and ...

"Louie had a series of blood tests a few weeks later and we were told he had severe haemophilia,” the mum, a marketing consultant from the Isle of Wight," Rosie said. “We were completely ...

Haemophilia is a rare genetic bleeding disorder that causes the blood to take a long time to clot because of a deficiency in one or several blood clotting factors. It is almost exclusively found ...

Several former pupils of the Lord Mayor Treloar School and College in Hampshire, which at the time was a boarding school for children with haemophilia, are taking legal action against the Treloar ...

An estimated 7700 people in England have haemophilia A, with around 1900 classified as severe cases where their factor VIII activity level is less than 1%. Current treatments involve factor VIII ...

A long-acting Factor VIII replacement therapy for haemophilia A from Sobi and Sanofi has been recommended for use by the NHS ...

Haemophilia, a genetic disorder characterised by deficient clotting factors, often leads to musculoskeletal complications such as haemophilic arthropathy. These complications result in reduced ...

At least 72 children died after being given a drug contaminated with HIV and viral hepatitis.